L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
XnApMbN5pZzhNM02
